Literature DB >> 24837556

Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition.

Henry Buchwald1, Robert B Dorman2, Nikolaus F Rasmus2, Van N Michalek2, Nichol M Landvik2, Sayeed Ikramuddin2.   

Abstract

BACKGROUND: We do not have a unified, scientifically tested theory of causation for obesity and its co-morbidities, nor do we have explanations for the mechanics of the metabolic/bariatric surgery procedures. Integral to proffered hypotheses are the actions of the hormones glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and leptin. The objective of this study was to obtain blood levels of GLP-1, PYY, and leptin after stimulation of the terminal ileum and cecum by a static infusion of a food hydrolysate in morbidly obese patients undergoing a duodenal switch procedure.
SETTING: University Hospital.
METHODS: Plasma levels of GLP-1, PYY, and leptin were obtained at 0, 30, 60, 90, and 120 minutes after instillation of 240 mL of a food hydrolysate into the ileum or cecum.
RESULTS: The mean±SD GLP-1 values by cecal stimulation for 0, 30, 60, 90, and 120 minutes were: 41.3±23.2; 39.6±21.8; 38.9±19.1; 47.4±22.3; 51.7±27.3 pM, and by ileal stimulation: 55.0±32.8; 83.4±16.1; 78.7±23.8; 84.7±23.5; 76.4±25.6. The mean±SD PYY values by cecal stimulation were: 62.1±24.8; 91.1±32.8; 102.1±39.6; 119.6±37.5; 130.3±36.7, and by ileal stimulation: 73.8±41.6; 138.1±17.7; 149.5±23.3; 165.7±24.3; 155.5±29.1. Percent change in PYY levels increased ~150%, GLP-1 increased ~50%, and leptin decreased ~20%.
CONCLUSION: Direct stimulation of the human terminal ileum and cecum by a food hydrolysate elicits significant plasma GLP-1 and PYY elevations and leptin decreases, peaking at 90-120 minutes. The ileal GLP-1 and PYY responses exceed those of the cecum, and the PYY effect is about 3-fold that of GLP-1. The results of this study question the satiety premise for ileal transposition.
Copyright © 2014 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Duodenal switch; GLP-1; Leptin; PYY

Mesh:

Substances:

Year:  2014        PMID: 24837556      PMCID: PMC5921075          DOI: 10.1016/j.soard.2014.01.032

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  50 in total

Review 1.  Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions.

Authors:  Garth H Ballantyne
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

2.  Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.

Authors:  A S Rocca; P L Brubaker
Journal:  Endocrinology       Date:  1999-04       Impact factor: 4.736

3.  Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

Authors:  E Rask; T Olsson; S Söderberg; O Johnson; J Seckl; J J Holst; B Ahrén
Journal:  Diabetes Care       Date:  2001-09       Impact factor: 19.112

4.  Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus.

Authors:  E Mannucci; A Ognibene; F Cremasco; G Bardini; A Mencucci; E Pierazzuoli; S Ciani; A Fanelli; G Messeri; C M Rotella
Journal:  Diabet Med       Date:  2000-10       Impact factor: 4.359

5.  Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.

Authors:  Ricardo Cohen; Pedro Paulo Caravatto; Jose Luis Correa; Patricia Noujaim; Tarissa Zanata Petry; João Eduardo Salles; Carlos Aurelio Schiavon
Journal:  Surg Obes Relat Dis       Date:  2012-02-02       Impact factor: 4.734

6.  Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon.

Authors:  O Nilsson; A J Bilchik; J R Goldenring; G H Ballantyne; T E Adrian; I M Modlin
Journal:  Endocrinology       Date:  1991-07       Impact factor: 4.736

7.  Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas.

Authors:  A Ali-Rachedi; I M Varndell; T E Adrian; D A Gapp; S Van Noorden; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1984

8.  Role of leptin in the regulation of glucagon-like peptide-1 secretion.

Authors:  Younes Anini; Patricia L Brubaker
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

9.  A comparison of intraduodenally and intracolonically administered nutrients on the release of peptide-YY in the dog.

Authors:  G H Greeley; T Hashimoto; M Izukura; G Gomez; J Jeng; F L Hill; F Lluis; J C Thompson
Journal:  Endocrinology       Date:  1989-10       Impact factor: 4.736

10.  GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery.

Authors:  Amanda Jiménez; Roser Casamitjana; Judith Viaplana-Masclans; Antonio Lacy; Josep Vidal
Journal:  Diabetes Care       Date:  2013-01-28       Impact factor: 19.112

View more
  8 in total

Review 1.  The evolution of metabolic/bariatric surgery.

Authors:  Henry Buchwald
Journal:  Obes Surg       Date:  2014-08       Impact factor: 4.129

2.  Ileal effect on blood glucose, HbA1c, and GLP-1 in Goto-Kakizaki rats.

Authors:  Henry Buchwald; Hector J Menchaca; Van N Michalek; Nestor T Bertin
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

3.  Comparison of Meal Pattern and Postprandial Glucose Response in Duodenal Switch and Gastric Bypass Patients.

Authors:  Inger Nilsen; Magnus Sundbom; Niclas Abrahamsson; Arvo Haenni
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

4.  Design and Synthesis of Analogues of Marine Natural Product Galaxamide, an N-methylated Cyclic Pentapeptide, as Potential Anti-Tumor Agent in Vitro.

Authors:  Jignesh Lunagariya; Shenghui Zhong; Jianwei Chen; Defa Bai; Poonam Bhadja; Weili Long; Xiaojian Liao; Xiaoli Tang; Shihai Xu
Journal:  Mar Drugs       Date:  2016-09-03       Impact factor: 5.118

Review 5.  Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications.

Authors:  Rushikesh Sable; Pravin Parajuli; Seetharama Jois
Journal:  Mar Drugs       Date:  2017-04-22       Impact factor: 5.118

6.  Identification of a novel angiogenic peptide from periostin.

Authors:  Ba Reun Kim; Yang Woo Kwon; Gyu Tae Park; Eun Jung Choi; Jeong Kon Seo; Il Ho Jang; Seung-Chul Kim; Hyun-Chang Ko; Sang Chul Lee; Jae Ho Kim
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

7.  Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity.

Authors:  Piotr Major; Maciej Matłok; Michał Pędziwiatr; Marcin Migaczewski; Anna Zub-Pokrowiecka; Dorota Radkowiak; Marek Winiarski; Anna Zychowicz; Danuta Fedak; Andrzej Budzyński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-09-11       Impact factor: 1.195

8.  Glycyl-alanyl-histidine protects PC12 cells against hydrogen peroxide toxicity.

Authors:  Hideki Shimura; Ryota Tanaka; Yoshiaki Shimada; Kazuo Yamashiro; Nobutaka Hattori; Takao Urabe
Journal:  BMC Biochem       Date:  2017-11-22       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.